William Blair & Company
AMPE

William Blair & Company’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

William Blair & Company’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-75
Closed -$11K – 1960
2022
Q1 		$11K Buy
75
+8
+12% +$1.17K ﹤0.01% 1830
2021
Q4 		$11K Buy
67
+17
+34% +$6.34K ﹤0.01% 1889
2021
Q3 		$25K Hold
50
– – ﹤0.01% 1757
2021
Q2 		$25K Hold
50
– – ﹤0.01% 1763
2021
Q1 		$25K Hold
50
– – ﹤0.01% 1734
2020
Q4 		$24K Hold
50
– – ﹤0.01% 1691
2020
Q3 		$14K Buy
+50
New +$12.4K ﹤0.01% 1611

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company's AMPE Position: Q2 2022 in Review

William Blair & Company sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 75 shares — an estimated $11K sold.

William Blair & Company first reported a position in AMPE in Q3 2020 and held it in 7 quarters. The position peaked at $25K in Q3 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • William Blair & Company reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • William Blair & Company sold 75 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $11K.
  • William Blair & Company first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 7 quarters.
  • William Blair & Company's Ampio Pharmaceuticals Inc. position peaked at $25K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on William Blair & Company's 13F filing for Q2 2022, filed 10 Aug 2022.